Aroa Biosurgery (ASX:ARX) has appointed Mark Dunwoodie as its new CFO and joint company secretary, effective November 16. Dunwoodie previously served as the chief financial officer of NZX-listed Rakon. They expect this change to bring new expertise to the company.
Auravelle Metals (ASX:AUV) has sold its Skeleton Rocks project in Western Australia to Forrestania Resources for $250,000 in shares. This move is expected to sharpen the company’s focus on its Nuckulla Hill and Crown projects, allowing it to allocate more resources to these areas.
Broken Hill Mines (ASX:BHM) has begun a drilling program at its Copper Blow copper-gold project, where it holds a 25% interest. The program, which is being carried out with joint venture partner Kingfisher Mining, aims to target a maiden resource. The company is working to achieve this goal through its joint efforts.
Clever Culture Systems (ASX:CC5) has secured $2.6 million in funding, which will be used to develop its APAS Revolution benchtop system. The system is designed for smaller pharmaceutical manufacturers, providing them with a new tool for their work.
Excite Technology Services (ASX:EXT) has earned Advanced partner status in the Fortinet Engage Partner Program for its Excite Cyber business. The company plans to use this status to build recurring managed security service revenue, expanding its services in this area.
Mount Ridley Mines (ASX:MRD) has reported a 96% recovery of vanadium from a titanomagnetite sample using its Selectro process. The process also recovered 49% of titanium and 78% of iron without requiring a high-temperature salt roast, demonstrating its potential.
Orthocell (ASX:OCC) has welcomed US FDA 510(k) clearance for PearlBone, a marine-derived bone graft substitute. Orthocell holds a 12% stake in the company that developed PearlBone and has a first right of refusal on distribution, giving it a significant interest in the product.
QMines (ASX:QML) has locked in firm commitments for a $5.5 million placement, which will be used to advance the Mt Chalmers copper-gold feasibility study. The placement includes investment from the Queensland Critical Minerals Fund, supporting the company’s work in this area.
RareX (ASX:REE) has confirmed a copper-nickel sulphide system at its Niobe prospect in Western Australia’s East Yilgarn. The company’s maiden Khaleesi drilling program has also identified broad gallium-rich regolith, providing new information about the area’s geology.
